Strong Market Position As the leading cord blood banking provider with over 900,000 stored units and high recommendation rates from OB/GYNs and expecting parents, CBR demonstrates a dominant presence in the biotechnology and fertility preservation market, presenting opportunities to target healthcare providers and expecting families.

Research Collaboration & Innovation CBR actively partners with research institutions and biotech companies, including notable collaborations on stem cell therapy and COVID-19 treatment development, indicating opportunities to engage with research organizations and pharma companies seeking cutting-edge stem cell solutions.

Expanding Employee and Customer Base With a workforce of up to 200 employees and ongoing hiring efforts, along with recent partnership expansions, CBR is positioned for growth, providing sales channels to offer new services, products, or educational resources to a broad and increasing customer base.

Funding and Growth Potential Having secured $18 million in funding and acquired by AMAG Pharmaceuticals for over half a billion dollars, CBR shows strong financial backing and growth momentum, making it a strategic partner for clinical trials, biotech investments, or supply chain collaborations.

Technology and Digital Engagement Utilizing advanced tech stacks and digital marketing tools, CBR actively engages consumers online, presenting opportunities to develop targeted digital campaigns, partnership promotions, or new educational platforms to reach families and healthcare providers directly.